UBS lowered the target price for HKBN (01310) to HKD3.16 from HKD3.50 and maintained the "neutral" rating.
The research house said it trims 2024-26e EBITDA by 3-7% and dividend by 14-30% due to assumptions of slower enterprise business turnaround and higher interest cost.
【母親節限時優惠】 送價值$288維柏健30天逆轉肌齡(膠原蛋白+生物素) ► 火速行動